Document Detail


Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90α
MedLine Citation:
PMID:  22441439     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Hsp90 inhibitors can enhance the tumour sensitivity to ionising radiation (IR). However, Hsp90 inhibition leads to the up-regulation of anti-apoptotic Hsp90 and Hsp70, which might diminish the radiosensitizing effects of the inhibitors. Therefore, inhibition of the up-regulation of Hsp90 by siRNA might be a promising strategy to enhance drug-mediated radiosensitization. MATERIALS AND METHODS: The expression of Hsp90α was silenced in A549 and GaMG tumour cell lines by siRNA treatment. Pre-silenced for Hsp90α cells were treated with NVP-AUY922, a novel Hsp90 inhibitor, for 24 h and then irradiated. Radiation response was determined by colony-forming ability. The expression of several marker proteins was analysed by Western blot. DNA damage and repair were assessed by histone γH2AX measurements. RESULTS: We found that transfection with siRNA against Hsp90α reduced Hsp90α at mRNA and protein levels. Pre-silencing of Hsp90α reduced NVP-AUY922-mediated up-regulation of Hsp90α but it did not increase drug-mediated radiosensitization in both tumour cell lines. As revealed by Western blot, pre-silencing of Hsp90α followed by NVP-AUY922 did not change the expression of Hsp90 client proteins (Akt, Raf-1, Cdk1 and Cdk4) compared with drug treatment alone, suggesting unchanged chaperone function in transfected cells. CONCLUSION: Pre-silencing of Hsp90α followed by Hsp90 inhibition did not enhance the radiosensitizing effect of NVP-AUY922 in both tested tumour cell lines. Future work will be done on stable transfection with shRNA against Hsp90α or simultaneous silencing of both Hsp90 isoforms, Hsp90α and Hsp90β, in order to optimize tumour cell killing.
Authors:
L Stingl; N Niewidok; N Müller; M Selle; C S Djuzenova; M Flentje
Related Documents :
22801959 - Simultaneous pan-pi3k and mek inhibition as a potential therapeutic strategy in periphe...
16819299 - Cage, a novel cancer/testis antigen gene, promotes cell motility by activation erk and ...
5778189 - Time lapse cinemicrographic studies of x-irradiated hela s3 cells. i. cell progression ...
9136899 - Icrf-193, a catalytic inhibitor of dna topoisomerase ii, delays the cell cycle progress...
19343259 - Cytochrome c-binding "proteo-dendrimers" as new types of apoptosis inhibitors working i...
1149049 - Amphotericin b-induced sensitivity to actinomycin d in drug-resistant hela cells.
19549869 - Connexin expression by radial glia-like cells is required for neurogenesis in the adult...
24205259 - Exchange of cytosolic content between t cells and tumor cells activates cd4 t cells and...
21544479 - Cell proliferation and apoptosis in the exocrine pancreas of azaserine-treated rats and...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-24
Journal Detail:
Title:  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]     Volume:  -     ISSN:  1439-099X     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8603469     Medline TA:  Strahlenther Onkol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Radiation Oncology, University of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany.
Vernacular Title:
Radiosensibilisierender Effekt des neuartigen Hsp90-Inhibitors NVP-AUY922 in Hsp90α-inhibierten humanen Tumorzelllinien.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanism investigation of ketone hydrogenation catalyzed by ruthenium bifunctional catalysts: insig...
Next Document:  Respiratory gated [(18)F]FDG PET/CT for target volume delineation in stereotactic radiation treatmen...